“c-difficile” Archives

in
Entry Author Date Location
Finch Therapeutics Fetches $90M to Advance Microbiome Drug Pipeline 09/17/20 Boston
Lumen Bioscience Lands $16M to Engineer “Edible” Antibody Drugs 09/02/20 Seattle
Seres Sets Sights on FDA After C. Diff Microbiome Therapy Scores in Phase 3 08/10/20 Boston
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More 08/16/19 National
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Summit Therapeutics Ditches Duchenne Drug In Wake of Phase 2 Failure 06/27/18 Boston
Trump v. Drug Makers? And 6 More Burning Biopharma Questions for 2018 01/02/18 National
FDA Turmoil, Biology Mystery On List Of Hurdles For Microbiome Drugs 02/14/17 New York
Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More 10/28/16 National
With Bugs As Drugs, Evelo CEO Plans Immune, Cancer Trials in 2017 07/12/16 Boston
Seres Inks Nestlé As Potential $2B Partner; Key Microbiome Data Soon 01/11/16 Boston
Evelo Launches With $35M To Fight Cancer With Cocktails of Bacteria 11/04/15 Boston
Bon Appetit: Seres And Its Microbiome Gut Treatment Notch $134M IPO 06/25/15 Boston
Gold Bugs? Seres Files For First IPO of Human Microbiome Era 05/27/15 Boston
One Week Into The New Year, Five Biotechs Reel in $220M Venture Cash 01/08/15 National
With Crossover Cash, Seres Health Aims For Big Microbiome Milestones 12/02/14 Boston
Microbiome Startup Seres Health Tabs Pharma Vet Pomerantz as CEO 06/02/14 Boston
AvidBiotics Taps Nature for Two Ways To Fight Lethal Microbes 04/03/14 San Francisco
Flagship Takes a Stab at Microbiome Therapy With Seres Health 11/21/13 Boston
Cubist Adds Antibiotic Punch, Buys Trius and Optimer for $1.24B 07/30/13 Boston
Synthetic Biologics, Fuelled by Billionaire, Takes Aim at C.Diff 05/02/13 Detroit Ann Arbor
San Diego Life Sciences Roundup: Optimer, Volcano, Avelas Bio, & More 12/07/12 San Diego
AvidBiotics Sees New Angle for Personalized Medicine in Antibiotics 02/01/12 San Francisco
Optimer, Following Pfizer’s Playbook, Has Big Plans for Antibiotic 01/31/12 San Diego
San Diego Life Sciences Roundup: BeneChill, Sotera, Imthera, & More 12/16/11 San Diego
Optimer Wins EU Approval for New Antibiotic 12/12/11 San Diego
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News 11/10/11 San Diego
FDA Approves Optimer Antibiotic, Amylin Wins Legal Round Against Lilly, Investors Excited by Orexigen Move, & More San Diego Life Sciences News 06/02/11 San Diego
Optimer Cruises Into Memorable Memorial Day Weekend, Awaiting FDA Word on Antibiotic 05/27/11 San Diego
Optimer Antibiotic Gets Panel Nod, CareFusion Buys Vestara, Tracon Raises $16.5M, & More San Diego Life Sciences News 04/07/11 San Diego
Page 1 of 2 next page »